Moreover, HMMR's interaction with low molecular weight hyaluronic acid (HA) fragments notably enhances immune cell recruitment and exacerbates patient prognosis by activating tumor microenvironment dynamics and influencing pathways such as CD44 expression41. The gene discussed is HMMR; the disease is neoplasm.